RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+30.53%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$1.67B
AUM Growth
+$1.67B
(+20%)
Cap. Flow
-$28.6M
Cap. Flow
% of AUM
-1.71%
Top 10 Holdings %
Top 10 Hldgs %
68.77%
Holding
48
New
8
Increased
25
Reduced
10
Closed
2
Top Buys
| 1 |
ProQR Therapeutics
PRQR
|
$72.4M |
| 2 |
Establishment Labs
ESTA
|
$18.1M |
| 3 |
VRAY
ViewRay, Inc.
VRAY
|
$17.9M |
| 4 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$17.4M |
| 5 |
ResMed
RMD
|
$17M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$107M |
| 2 |
Regenxbio
RGNX
|
$46.8M |
| 3 |
PTC Therapeutics
PTCT
|
$37.5M |
| 4 |
Solid Biosciences
SLDB
|
$19.5M |
| 5 |
Arrowhead Research
ARWR
|
$13.3M |
Sector Composition
| 1 | Healthcare | 92.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Rocket Pharmaceuticals
RCKT
$354M
| $369M | 22.07% | 14,969,744 | – | – |
|
|
2
PTC Therapeutics
PTCT
$3.92B
| $154M | 9.22% | 3,275,591 -798,099 | -20% | -$37.5M |
|
|
3
Arrowhead Research
ARWR
$3.05B
| $146M | 8.73% | 7,604,225 -695,317 | -8% | -$13.3M |
|
|
4
Regenxbio
RGNX
$451M
| $110M | 6.6% | 1,459,128 -620,427 | -30% | -$46.8M |
|
|
DRNA
5
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $83.3M | 4.99% | 5,461,124 +416,311 | +8% | +$6.35M |
|
|
6
ProQR Therapeutics
PRQR
$237M
| $72.4M | 4.33% | +3,739,406 | New | +$72.4M |
|
7
Bristol-Myers Squibb
BMY
$96B
| $58.8M | 3.52% | 946,961 +43,289 | +5% | +$2.69M |
|
8
LivaNova
LIVN
$3.08B
| $54.9M | 3.29% | 443,036 +12,036 | +3% | +$1.49M |
|
|
9
Sarepta Therapeutics
SRPT
$1.78B
| $50.7M | 3.04% | 314,070 -664,481 | -68% | -$107M |
|
|
ACHN
10
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $50M | 3% | 13,595,704 +53,707 | +0.4% | +$198K |
|
11
Masimo
MASI
$7.59B
| $38.7M | 2.32% | 310,461 +60,918 | +24% | +$7.59M |
|
12
Arbutus Biopharma
ABUS
$711M
| $38.6M | 2.31% | 4,084,904 -1,080,595 | -21% | -$10.2M |
|
|
CORI
13
DELISTED
Corium International, Inc.
CORI
| $34.3M | 2.06% | 3,610,632 +1,687,415 | +88% | +$16M |
|
14
Alnylam Pharmaceuticals
ALNY
$58.5B
| $34.1M | 2.04% | 389,072 +36,872 | +10% | +$3.23M |
|
|
VRAY
15
DELISTED
ViewRay, Inc.
VRAY
| $31.7M | 1.9% | 3,389,498 +1,915,342 | +130% | +$17.9M |
|
16
Vericel Corp
VCEL
$1.83B
| $31.4M | 1.88% | 2,217,916 | – | – |
|
17
Illumina
ILMN
$15.8B
| $30.3M | 1.82% | 82,621 +32,963 | +66% | +$12.1M |
|
18
Qiagen
QGEN
$10.1B
| $29.4M | 1.76% | 775,324 +245,939 | +46% | +$9.32M |
|
|
LJPC
19
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $24.1M | 1.44% | 1,197,107 -148,774 | -11% | -$2.99M |
|
|
AGEN
20
Agenus
AGEN
$133M
| $21M | 1.26% | 9,824,579 +449,128 | +5% | +$961K |
|
|
21
Establishment Labs
ESTA
$1.2B
| $18.1M | 1.08% | +775,809 | New | +$18.1M |
|
|
MYOK
22
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $17.9M | 1.07% | 273,917 +12,522 | +5% | +$816K |
|
|
PRNB
23
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $17.4M | 1.04% | +644,448 | New | +$17.4M |
|
|
24
ResMed
RMD
$40.2B
| $17M | 1.02% | +147,400 | New | +$17M |
|
25
Apyx Medical
APYX
$75.3M
| $15.9M | 0.95% | 2,235,547 +153,410 | +7% | +$1.09M |
|